Skip to main
AHR
AHR logo

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 30%
Buy 70%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

American Healthcare REIT Inc. is positioned to enhance its revenue streams, particularly through Medicare Advantage plans, which are designed to incentivize superior operational outcomes. The company anticipates a resurgence in the attractiveness of outpatient medical buildings, leveraging demographic trends that are favorable across various healthcare real estate sectors. Additionally, the favorable supply and demand dynamics present a significant growth runway, reinforcing American Healthcare REIT's market positioning and potential for sustained revenue generation.

Bears say

The analysis reveals that American Healthcare REIT is currently facing significant financial pressures, primarily due to a heightened net debt/EBITDA ratio of 3.7x, suggesting potential over-leverage concerns in a volatile market. Additionally, the REIT is exposed to multiple external risks, including a possible resurgence of COVID-19, adverse flu seasons, and unfavorable changes in investment yields or cost of capital, which could further strain its financial stability. Compounding these issues, anticipated developments in larger markets indicate that stabilized yields may only reach around 6% in the future, with occupancy levels projected to be between 85% and 90%, introducing additional uncertainty to revenue prospects.

AHR has been analyzed by 10 analysts, with a consensus rating of Buy. 30% of analysts recommend a Strong Buy, 70% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 10 analysts, AHR has a Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $43.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $43.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.